Figure 3.
Year 1 of the 2‐year titration regimens selected for testing in SR/MR OLEs. APOEε4, apolipoprotein E ε4; MR, Marguerite RoAD; OLE, open‐label extension; PBO, placebo; SR, SCarlet RoAD.
Year 1 of the 2‐year titration regimens selected for testing in SR/MR OLEs. APOEε4, apolipoprotein E ε4; MR, Marguerite RoAD; OLE, open‐label extension; PBO, placebo; SR, SCarlet RoAD.